| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $39.8M | +5.8% | +51.5% |
| SG&A Expense | $6.8M | -18.2% | +0.1% |
| Operating Income | -$46.6M | -1.5% | -41.0% |
| Interest Expense | $584K | +2.3% | — |
| Income Tax | $0 | — | — |
| Net Income | -$44.9M | +0.6% | -46.5% |
| EPS (Basic) | -$0.44 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $60.2M | -58.7% | -64.7% |
| Short-term Investments | $99.7M | +103.2% | +704.0% |
| Current Assets | $164.6M | -17.1% | -11.3% |
| Total Assets | $189.8M | -15.5% | -7.2% |
| Current Liabilities | $45.7M | +10.1% | +99.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$95.7M | — | — |
| Capital Expenditures | $1.0M | — | — |
| Investing Cash Flow | -$100.1M | — | — |
| Financing Cash Flow | $92.0M | — | — |
| Free Cash Flow | -$96.8M | — | — |
| +29.0% |
| EPS (Diluted) | -$0.44 | +39.7% | +29.0% |
| $50.3M |
| +9.3% |
| +66.7% |
| Stockholders' Equity | $139.5M | -21.9% | -20.0% |